i will be interested to see how much is being raised. in a way it's quite amazing that a company with promising breast cancer data and so many other irons in the fire (I.e. clinical trials with read outs this year) has a market cap of $12M.
there are other companies out there such as 1AD which have double the market cap and haven't even started trials (although admittedly 1AD is somewhat of an anomaly).
don't understand why PTX isn't $30M-100M (as a starting point)
